Announcement:

New scientific publication in collaboration with the University of Newcastle on modelling Stargardt disease (STGD1) in vitro with retinal organoids (RO) to unravel genotype-phenotype correlations

Find out more

Home › Resources › Fact sheets › High throughput, high sensitivity (HTHS) lung fibroblast-to-myofibroblasts transition (FMT) assay for anti-fibrotic drug screening

High throughput, high sensitivity (HTHS) lung fibroblast-to-myofibroblasts transition (FMT) assay for anti-fibrotic drug screening

Published

26th June, 2024

Published by

Newcells Biotech

Share on social media:

Don't miss out on our latest innovations: follow us on Linkedin

View this resource

Please click the button below to download this resource.

Download the overview of the Lung FMT assay

Book a Call